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Abstract
Background: The field of proteomics aims to characterize
dynamics in protein function on a global level. However, several
classes of proteins, in particular low abundance proteins, remain
difficult to characterize using standard proteomics technologies.
Recently, chemical strategies have emerged that profile classes of
proteins based on activity rather than quantity, thereby greatly
facilitating the analysis of low abundance constituents of the
proteome.
Results : In order to expand the classes of proteins susceptible to
analysis by activity-based methods, we have synthesized a library
of biotinylated sulfonate esters and applied its members to
complex proteomes under conditions that distinguish patterns of
specific protein reactivity. Individual sulfonates exhibited unique
profiles of proteome reactivity that in extreme cases appeared
nearly orthogonal to one another. A robustly labeled protein was
identified as a class I aldehyde dehydrogenase and shown to be
irreversibly inhibited by members of the sulfonate library.
Conclusions: Through screening the proteome with a non-
directed library of chemical probes, diverse patterns of protein
reactivity were uncovered. These probes labeled protein targets
based on properties other than abundance, circumventing one of
the major challenges facing contemporary proteomics research.
Considering further that the probes were found to inhibit a target
enzyme’s catalytic activity, the methods described herein should
facilitate the identification of compounds possessing both selective
proteome reactivities and novel bioactivities. ß 2001 Elsevier
Science Ltd. All rights reserved.
Keywords: Proteomics ; Sulfonate; Activity-based; Probe; Aldehyde de-
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1. Introduction
With the complete sequence of the human genome
nearly in hand, biological research is entering a new era
in which experimental focus will shift from identifying
novel genes to determining the function of gene products.
In e¡orts to accelerate the functional analysis of products
expressed by the genome, researchers have developed sev-
eral technologies that permit the study of biomolecules
collectively, rather than individually. These global exper-
imental strategies include: (1) genomics, or the analysis of
a cell’s complete transcript repertoire (transcriptome) [1,2],
and (2) proteomics, or the analysis of a cell’s complete
protein repertoire (proteome) [3,4]. In the ¢eld of ge-
nomics, advances in gene array technologies have permit-
ted researchers to compare in a single experiment the lev-
els of several thousand transcripts across two or more test
samples [1,2,5]. Recent studies have demonstrated how
gene chips can be used to discover and predict new sub-
classes of cancer based on their distinctive patterns of gene
expression [6,7]. Still, by measuring dynamics in mRNA
abundance, genomics approaches o¡er only an indirect
assessment of protein quantity and function. Considering
that mRNA levels are often poor predictors of protein
abundance [8,9], the degree to which genomics data are
re£ective of changes in protein function remains unclear.
Recently, proteomics initiatives have emerged with the
goal of characterizing dynamics in the abundances of pro-
teins themselves [3,4,10]. Considerable experimental chal-
lenges face the analysis of the proteome, especially when
compared to the technically more feasible pro¢ling of the
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transcriptome. Unlike mRNA molecules, proteins (1) dis-
play tremendous chemical diversity (e.g. various co- and
post-translational modi¢cations, hydrophobic domains,
etc.), (2) are not ampli¢able, and (3) do not typically pos-
sess de¢ned high a⁄nity and high selectivity binding part-
ners. Thus, perhaps not surprisingly, a general experimen-
tal method for total proteome analysis remains an elusive
goal. To date, most proteomics studies have relied on two-
dimensional gel electrophoresis (2DE) and mass spectrom-
etry (MS) as their separation and detection technologies,
respectively [11]. Advances in 2DE-MS methods have in-
creased their reproducibility and throughput for proteome
analysis [12]. However, a signi¢cant fraction of the pro-
teome still remains di⁄cult to analyze by 2DE, including
very large and small proteins, very basic and acidic pro-
teins, membrane proteins, and low abundance proteins
[11^13]. In order to permit the general and systematic
pro¢ling of such 2DE-resistant proteins, proteomics re-
searchers have proposed that alternative protein separa-
tion technologies must be developed [11,13]. Regardless,
even if the requisite advances in separation strategies are
achieved, it is critical to recognize that as long as proteo-
mics focuses on measuring exclusively changes in protein
abundance, it will provide, like genomics, only an indirect
assessment of dynamics in protein function. Numerous
post-translational events that regulate protein activity, es-
pecially those mediated by protein^protein and/or protein^
small molecule interactions, will remain undetected by
standard protein abundance-based techniques.
We have initiated a research program aimed at generat-
ing chemical probes that pro¢le components of the pro-
teome in an activity-dependent manner. In their broadest
application, such activity-based probes (ABPs) would de-
tect : (1) a signi¢cant, but manageable fraction of the pro-
teome, (2) low abundance proteins and proteins with
problematic biochemical properties (e.g. membrane pro-
teins), and (3) dynamics in the activity of proteins inde-
pendent of changes in their quantity. A prototype agent, a
biotinylated £uorophosphonate (FP-biotin), was recently
synthesized and shown to serve as an ABP for the serine
hydrolase superfamily of enzymes [14]. Similarly, biotinyl-
ated epoxides and electrophilic ketones have been used to
pro¢le subclasses of the cysteine protease family [15^17].
In each of these examples, researchers exploited a wealth
of previous knowledge on class-selective reactive groups
and/or molecular sca¡olds to create ABPs with predictable
proteome reactivities (e.g. FPs for pro¢ling serine hydro-
lases). However, for a number of protein families, selective
active site-directed a⁄nity reagents have not yet been iden-
ti¢ed, and whether such classes of proteins can be pro¢led
in the manner illustrated above remains uncertain. Herein,
we describe a non-directed approach for discovering new
ABPs that bear both reactivities and selectivities compat-
ible with whole proteome analysis. Additionally, we show
that these chemical probes directly a¡ect the activity of
their target proteins, highlighting their potential utility in
function-based screens as well as proteomics investiga-
tions.
2. Results
2.1. Selection and synthesis of biotinylated sulfonate esters
as candidate ABPs
In order to facilitate the discovery of new ABPs, we
adopted a non-directed strategy for pro¢ling the chemical
reactivity of the proteome. A library of candidate ABPs
was synthesized based on the general sca¡old outlined in
Fig. 1. The structure of an ABP was conceptually divided
into four pieces : a binding group (BG), a reactive group
(RG), a linker (L), and a tag (T). The library’s reactive
group was selected as a sulfonate ester, based on the fol-
lowing criteria. Sulfonates are: (1) moderately reactive
electrophiles, (2) relatively unexplored as protein labeling
reagents in biological systems, and (3) facile to modify
with a variety of chemical structures. Additionally, we
hoped that by choosing a carbon electrophile as the li-
brary’s reactive group, its bias towards particular enzyme
Fig. 1. A: General structure of an ABP, highlighting the probe’s four
main components: a binding group (BG), a reactive group (RG), a link-
er (L), and a tag (T). B: Structures of members of an ABP library,
where the BG is varied, the RG is a sulfonate ester, the L is an ex-
tended alkyl chain, and the T is biotin.
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classes would be minimized. Indeed, other carbon electro-
philes like epoxides have been found to engage a large
variety of enzymes through the alkylation of one of several
di¡erent types of active site amino acids, including cys-
teine hydrolases (cysteines) [17], metallohydrolases (histi-
dines) [18^20], glycosidases (glutamates/aspartates) [21],
and proteosomal subunits (N-terminal amines) [22]. The
library’s binding group was combinatorially varied, while
its linker moiety was kept constant and served as a bridge
to the chemical tag (biotin). Through varying the binding
group, we hoped to direct the sulfonate’s speci¢c proteome
reactivity to di¡erent proteins and/or protein classes.
A series of biotinylated sulfonates (1^11 ; Fig. 1) were
synthesized according to the three step sequence outlined
in Scheme 1. The corresponding aryl or alkylsulfonyl chlo-
ride was added slowly to a solution of undecene-1-ol (12)
dissolved in pyridine at 0‡C to form the sulfonate (13).
The procedure of Sharpless and colleagues was utilized
to oxidatively cleave the terminal ole¢n, resulting in for-
mation of the corresponding carboxylic acid (14) [23].
Treatment of 14 with diethylaminosulfur tri£uoride fol-
lowed by the addition of N-hydroxysuccinimide a¡orded
the N-hydroxysuccinimidyl ester intermediate. The latter
compound was reacted with commercially available 5-(bio-
tinamido)pentylamine (NH2-biotin, Pierce) in methanol to
form the desired biotinylated sulfonate ester.
2.2. Evaluating the speci¢c proteome reactivity of
biotinylated sulfonates
To determine whether members of the sulfonate library
speci¢cally targeted proteins in the proteome, a method
was developed to rapidly distinguish a probe’s speci¢c
and non-speci¢c proteome reactivities. Each sulfonate (5
WM) was reacted with two versions of a rat testis pro-
teome: a native proteome and a denatured proteome (gen-
erated by preheating the protein sample for 5 min at
80‡C). After 30 min at 25‡C, the sulfonate^proteome re-
actions were quenched by adding one reaction volume of
standard sodium dodecyl sulfate (SDS)^PAGE loading
bu¡er and analyzed by SDS^PAGE and avidin blotting.
A sulfonate’s speci¢c and non-speci¢c proteome reactivity
were de¢ned as those protein targets that displayed heat-
sensitive and heat-insensitive labeling, respectively. All sul-
fonates except the octylsulfonate 7 labeled at least one
member of the testis proteome in a heat-sensitive manner
(Fig. 2A,B). Interestingly, four general patterns of speci¢c
proteome reactivity were observed among the sulfonates.
The p-toluenesulfonate 3, butylsulfonate 6, and naphthyl-
sulfonate 10 each speci¢cally labeled one 55 kDa protein
(Fig. 2A,B; single arrowhead). The p-methoxybenzenesul-
fonate 4 and methylsulfonate 5 labeled four members of
the proteome in a heat-sensitive manner (Fig. 2A; 55 kDa
(single arrowhead), 42 kDa (double arrowhead), 40 kDa
(triple arrowhead), and 32 kDa (single dot)), but also
showed signi¢cant additional reactivity with the preheated
proteome. The benzenesulfonate 2 reacted with three of
the four proteins labeled by 4 and 5, failing to speci¢cally
label only the 40 kDa protein. The p-nitrobenzenesulfo-
Scheme 1. Synthetic route for the generation of biotinylated sulfonate
esters.
Fig. 2. Speci¢c and non-speci¢c proteome reactivities of sulfonates 1^7
(A) and 8^11 (B). For A and B, each sulfonate’s reactivity with both a
heated and unheated version of a rat testis proteome is shown (standard
reaction conditions: 5 WM sulfonate, 0.5 Wg/Wl testis protein, 50 mM
Tris^HCl, pH 8.0, 100 mM NaCl; 30 min reaction, 25‡C). Sulfonate-la-
beled proteins were detected by SDS^PAGE (7.5 Wg protein/lane) and
avidin blotting. Highlighted with arrowheads and dots are proteins that
reacted with sulfonates in a heat-sensitive manner (see text). The pro-
teins labeled in the lanes containing preheated proteomes (v) were all
considered ‘non-speci¢c’ sulfonate reactivities, except an 80 kDa protein
which represented an endogenous avidin-reactive protein (i.e. also ob-
served in proteomes not treated with sulfonates; see Fig. 4B). Di¡erent
¢lm exposure times are presented for the high (45^100 kDa, 1U time
exposure) and low (27^45 kDa, 4U time exposure) molecular mass pro-
teins to permit the signals of labeled proteins to be shown prior to ¢lm
saturation.
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nate 8, quinolinesulfonate 9, and thiophenesulfonate 11
each reacted speci¢cally with a 55 kDa protein, as well
as two additional proteins poorly labeled by the other
reagents (Fig. 2B; 36 kDa (single dot) and 30 kDa (triple
dot)). Finally, the pyridylsulfonate 1 labeled a 55 kDa
protein and a 31 kDa protein (Fig. 2A,B, single arrowhead
and double dot, respectively), the latter protein appearing
uniquely reactive with 1 among the sulfonates that were
surveyed. Importantly, most of the sulfonate probes with
the exception of 2, 4, and 5 showed low or negligible
reactivity with the preheated proteome.
Although several sulfonate probes showed overlapping
patterns of speci¢c proteome reactivity, their relative reac-
tivities with individual proteins di¡ered considerably. For
example, a 36 kDa protein reacted more strongly with
quinolinesulfonate 9 than with pyridylsulfonate 1, p-nitro-
benzenesulfonate 8 or thiophenesulfonate 11, while a 55
kDa protein displayed the opposite probe selectivity (Fig.
2B). To further examine the di¡erent proteome reactivities
exhibited by individual sulfonates, the labeling pattern of
pyridylsulfonate 1 was compared to that of methylsulfo-
nate 5 and quinolinesulfonate 9 in side-by-side analyses
(Fig. 3A,B, respectively). Sulfonates 1 and 5 exhibited
quite distinctive patterns of speci¢c proteome reactivity,
with 1 most strongly labeling 55 and 31 kDa proteins
(Fig. 3A, left panel, double arrowheads) and 5 most
strongly labeling 42 and 32 kDa proteins (Fig. 3A, left
panel, single arrowheads). A comparison of the proteome
reactivities of 1 and 9 identi¢ed two proteins that showed
preferred reactivity with 1 (Fig. 3B, left panel, 55 kDa and
31 kDa; double arrowheads) and two proteins that
showed enhanced reactivity with 9 (Fig. 3B, left panel,
36 kDa and 30 kDa; single arrowheads).
The greater non-speci¢c reactivity of 5 was also evident
in these side-by-side comparisons, as this agent labeled
several proteins in a heat-insensitive manner that were
unreactive towards 1 and 9. Notably, a Coomassie blue-
stained protein gel revealed that the proteins labeled by 5
in the preheated proteome represented very abundant pro-
teins (Fig. 2C, right panel, single arrowheads), consistent
with the notion that heat-insensitive labeling re£ects a
non-speci¢c form of sulfonate reactivity. In contrast, the
sulfonate library’s heat-sensitive proteome reactivity
showed no such bias towards abundant proteins. Finally,
it is interesting to note that little correlation was observed
between the magnitudes of a sulfonate’s speci¢c and non-
speci¢c forms of proteome reactivity, as several probes
displaying low reactivity with the preheated proteome ex-
hibited speci¢c reactivities that equaled or exceeded in in-
tensity those exhibited by probes with high non-speci¢c
reactivities.
2.3. Parameters that in£uence a sulfonate’s speci¢c
proteome reactivity
The following features of the sulfonate^proteome reac-
tion were varied in order to test their in£uence on the
observed speci¢c and non-speci¢c protein labeling pat-
terns: time, sulfonate concentration, pH, and the pres-
ence/absence of scavenging nucleophiles. For these studies,
the reactivity of pyridylsulfonate 1 with the testis pro-
teome was examined. The two testis proteins speci¢cally
targeted by 1 were labeled at similar rates, with their signal
intensities increasing from 5 to 40 min and then plateauing
from 40 to 120 min (Fig. 4A). The absence of additional
reactivity from 40 to 120 min could signify that the pro-
teins had labeled to completion by 40 min, or alterna-
tively, that the concentration of 1 in the reaction was sig-
ni¢cantly depleted by these later time points (this latter
explanation seems less likely when taking into account
that pyridylsulfonates were quite stable to the assay con-
ditions employed; see below).
Sulfonate 1’s speci¢c and non-speci¢c proteome reactiv-
ities were evaluated over a range of probe concentrations
(1^50 WM). From 1 to 10 WM, sulfonate 1 showed speci¢c
reactivity with the 31 and 55 kDa proteins that increased
in intensity with increasing concentrations of reagent (Fig.
Fig. 3. Side-by-side comparisons of the proteome reactivities of sulfo-
nates 1, 5, and 9. A: Left panel, proteome reactivities of sulfonates 1
and 5. Heat-sensitive protein reactivities selective for 1 and 5 are high-
lighted (double and single arrowheads, respectively). Right panel, Coo-
massie blue-stained protein gel of samples treated with 1 and 5. Arrow-
heads highlight abundant proteins correlating in molecular mass with
proteins labeled by 5 in the preheated proteome. B: Left panel, pro-
teome reactivities of sulfonates 1 and 9. Heat-sensitive protein reactiv-
ities selective for 1 and 9 are highlighted (double and single arrowheads,
respectively). Right panel, Coomassie blue-stained protein gel of samples
treated with 1 and 9. For A and B, di¡erent ¢lm exposure times are
presented for the high (45^100 kDa, 1U time exposure) and low (27^45
kDa, 4U time exposure) molecular mass proteins to permit the signals
of labeled proteins to be shown prior to ¢lm saturation.
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4B). Over this concentration range, sulfonate 1 displayed
very low levels of heat-insensitive reactivity with the pro-
teome. From 10 to 50 WM of 1, the signal intensity of the
31 kDa protein continued to increase, while the intensity
of the 55 kDa protein remained relatively constant. Over
this concentration range, sulfonate 1’s non-speci¢c label-
ing increased dramatically, especially in the higher molec-
ular mass range where most of the abundant testis pro-
teins reside. Importantly, however, no new speci¢cally
labeled protein targets were identi¢ed over this concentra-
tion range. Thus, a concentration range of 5^10 WM ap-
peared optimal for maximizing sulfonate 1’s speci¢c versus
non-speci¢c proteome reactivity.
The non-speci¢c and speci¢c proteome reactivities of
sulfonate 1 showed di¡erent pH-dependencies, with the
former appearing as an inverted bell-shape curve (higher
background labeling at pH 6 and 9 than at pH 7 and 8)
and the latter increasing in intensity from pH 6 to 8 and
plateauing from pH 8 to 10 (Fig. 4C,D). Thus, reactions
conducted at pH 7 and 8 produced the highest level of
speci¢c reactivity, while at the same time resulting in the
lowest degree of non-speci¢c reactivity.
Sulfonate 1’s intrinsic reactivity with nucleophiles was
examined by conducting proteome reactions in the pres-
ence of millimolar concentrations of free thiols (gluta-
thione, L-mercaptoethanol, or dithiothreitol (DTT)). If
this sulfonate displayed a high reactivity with generic nu-
cleophiles, then the probe’s e¡ective concentration in thiol-
treated proteome reactions should be greatly reduced, re-
sulting in a signi¢cant decrease in the signal intensity of
speci¢cally labeled proteins. However, none of the tested
thiols a¡ected the labeling intensity of the 55 kDa protein,
indicating that sulfonate 1’s intrinsic reactivity with nucle-
ophiles is low (Fig. 4D; see below for more evidence in
support of this notion). In contrast, a moderate decrease
in the labeling intensity of the 31 kDa protein was detected
in the presence of free thiols, possibly indicating that this
protein’s structure/activity is sensitive to these reagents
(e.g. if this protein’s tertiary structure is stabilized by di-
sul¢de bonds).
Fig. 4. Parameters that a¡ect the proteome reactivity of pyridylsulfonate 1. A: Time-dependence of 1^proteome reaction (5 WM of 1, 0.5 Wg/Wl protein,
50 mM Tris^HCl, pH 8.0). B: Concentration-dependence of 1^proteome reaction. Left panel, 1, 2.5, and 5 WM concentrations of 1 were reacted with
the testis proteome (0.5 Wg/Wl protein, 50 mM Tris^HCl, pH 8.0, 30 min reaction). Right panel, 5, 10, 20, and 50 WM concentrations of 1 were reacted
with the testis proteome (0.5 Wg/Wl protein, 50 mM Tris^HCl, pH 8.0, 30 min reaction). Short (upper right panel) and long (lower right panel) ¢lm ex-
posures of these reactions are shown. Note the presence of an endogenous 80 kDa avidin-reactive protein in the lane containing an untreated testis pro-
teome. C: pH-dependence of 1^proteome reaction (5 WM of 1, 0.5 Wg/Wl protein, 30 min reaction). Left panel, reactions conducted from pH 6.0 to 8.0.
Right panel, reactions conducted from pH 8.0 to 10.0. D: Thiol-dependence of 1^proteome reaction. Control reactions were conducted under standard
conditions. Each thiol (2 mM) was added to the proteome prior to the addition of 1.
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2.4. Molecular identi¢cation of a protein labeled by
biotinylated sulfonates
The screening method described above was enacted to
rapidly identify protein targets speci¢cally labeled by
members of the sulfonate library. By de¢ning these ‘spe-
ci¢c protein targets’ as ones that displayed heat-sensitive
reactivity with sulfonates, we hoped to restrict our focus
to proteins whose activities would be a¡ected by sulfonate
labeling. The assumption inherent to this strategy was that
heat-sensitive labeling was re£ective of an event taking
place within a structured portion of a protein suitable
for small molecule binding. Such structures were antici-
pated to often represent either ligand binding pockets of
receptors or active sites of enzymes. As such, if a sulfonate
reacted speci¢cally with one of these sites on a receptor or
an enzyme, its reaction might in turn be expected to a¡ect
the activity of this protein. In order to test this premise, we
pursued the molecular identi¢cation of the 55 kDa protein
speci¢cally labeled by several members of the sulfonate
library.
A tissue blot with sulfonate 1 revealed that the labeled
55 kDa protein was most abundant in soluble fractions of
rat liver (data not shown), and therefore the protein was
puri¢ed from this source. The 55 kDa protein was parti-
ally puri¢ed by Q-Sepharose anion exchange chromatog-
raphy. Aliquots of the £ow-through and elution fractions
of this column were labeled with 1, and the 55 kDa protein
was identi¢ed in the £ow-through fractions. These frac-
tions were combined, labeled with 5 WM 1 for 30 min,
and the protein separated from excess sulfonate by size
exclusion chromatography. The protein sample was then
treated with avidin agarose beads to isolate the 1-labeled
55 kDa protein. Elution of the avidin-bound proteins was
achieved by adding one volume of standard SDS^PAGE
loading bu¡er and heating (90‡C, 5 min). This avidin-
based a⁄nity puri¢cation procedure provided a highly
concentrated sample of the 55 kDa protein that was sep-
arated by SDS^PAGE and either blotted with avidin (Fig.
5A) or stained with Coomassie blue. The 55 kDa protein
was excised from the stained gel, treated with trypsin, and
the resulting peptide mixture analyzed by matrix-assisted
laser desorption ionization time-of-£ight (MALDI-TOF)
MS. MS-Fit and ProFound searches of protein databases
identi¢ed the protein as cytosolic 2 class I aldehyde dehy-
drogenase (cALDH-I; nine tryptic peptides ranging from
1189 to 2055 Da matched this enzyme, 50% total sequence
coverage; Fig. 5A), a member of a superfamily of NAD-
dependent enzymes responsible for the oxidation of endog-
enous and exogenous aldehydes to carboxylic acids [24,25].
2.5. Recombinant expression of cALDH-I
In order to con¢rm the speci¢c reactivity of cALDH-I
with sulfonate 1, this protein was recombinantly expressed
in both eukaryotic and prokaryotic systems. The cALDH-
I cDNA was subcloned into the pcDNA3 mammalian ex-
pression vector and then transfected into COS-7 and
MCF-7 cells. cALDH-I-transfected COS-7 and MCF-7
cells both expressed a 55 kDa protein that labeled strongly
with sulfonate 1 (Fig. 5B). In contrast, this sulfonate-re-
active protein was not detected in mock-transfected ver-
sions of each cell type. cALDH-I was also recombinantly
expressed in Escherichia coli using the pTrcHis system.
Lysates from cALDH-I-transformed E. coli were treated
with sulfonate 1 and found to express a single reactive
protein of the predicted size for the cALDH-I enzyme
bearing an N-terminal histidine tag (60 kDa; Fig. 5C).
The His-tagged cALDH-I was puri¢ed from E. coli lysates
by sequential metal a⁄nity and gel ¢ltration chromatog-
raphy. This prokaryotic expression system routinely pro-
vided 15 mg/l culture volume of puri¢ed cALDH-I en-
zyme.
Members of the sulfonate library displayed a relatively
broad range of apparent reactivities with cALDH-I in the
soluble testis proteome, with some probes labeling the 55
kDa enzyme quite strongly and others displaying little or
no reactivity towards this protein (see Fig. 2). In order to
determine whether the sulfonate labeling events observed
for the 55 kDa protein in the testis proteome re£ected
reactivity primarily with cALDH-I, several sulfonate
probes were incubated with cALDH-I-transfected COS-7
extracts. Interestingly, the relative reactivities of sulfonates
with the COS-expressed cALDH-I enzyme matched
closely their relative labeling e⁄ciencies with the 55 kDa
testis protein (Fig. 5D), indicating that the sulfonate label-
ing pattern observed at this molecular mass in the testis
proteome was predominantly due to cALDH-I.
2.6. Pyridylsulfonates are time-dependent inhibitors of
cALDH-I catalytic activity
cALDH-I-catalyzed oxidation of propionaldehyde to
propionic acid was measured by observing the reduction
of NAD to NADH at 340 nm. The observed Michaelis
constant for propionaldehyde (Km = 4.2 WM) displayed by
the His-tagged recombinant cALDH-I was comparable to
the reported literature value for this enzyme (Km = 6.5 WM)
[26]. To examine the e¡ect of sulfonates on cALDH-I’s
catalytic activity, the enzyme was treated with varying
concentrations of 2-pyridylsulfonyl octanoate (15), a var-
iant of 1 lacking the probe’s biotin tag. Sulfonate 15 in-
hibited cALDH-I’s catalytic activity in a time-dependent
manner that increased in rate from 2.5 to 15 WM inhibitor
(Fig. 6A). Concentrations of 15 greater than 15 WM inac-
tivated cALDH-I at a rate that was too fast to measure
under the assay conditions employed. The average Kobs/[I]
value calculated from reactions conducted at 2.5, 5.0, 7.5,
10, and 15 WM 15 was (9.7 þ 1.8)U103 M31 min31.
Although the inactivation of cALDH-I at each concentra-
tion of 15 could be ¢t to pseudo-¢rst order kinetics, ex-
trapolation of these reactions back to time zero did not
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predict 100% enzyme activity. Considering that cALDH-I
is a homotetrameric protein [27], one possible explanation
for these data was that individual cALDH-I subunits ex-
hibited di¡erent rates of reactivity with 15. In general sup-
port of this notion, the kinetics of reactions conducted at
lower concentrations of 15 appeared biphasic in nature,
with time points preceding 50% enzyme inhibition predict-
ing a slightly faster rate of cALDH-I inactivation than
time points at which greater than 50% cALDH-I activity
was inhibited. Finally, incubating 15 in the reaction bu¡er
Fig. 5. Identi¢cation of a 55 kDa speci¢cally labeled sulfonate target as cALDH-I. A: Avidin-based a⁄nity isolation of the 55 kDa 1-labeled protein.
Shown is an avidin blot of samples containing the partially puri¢ed 55 kDa protein (Q Flow Through) and the a⁄nity-isolated 55 kDa protein (Avidin
Beads). Also shown are the tryptic peptides from this protein that identi¢ed it as cALDH-I. B: Sulfonate 1 labels recombinant cALDH-I in eukaryotic
expression systems. Protein samples from COS-7 (left panel) and MCF-7 (right panel) cells transfected with the cALDH-I cDNA or empty vector
(mock) were reacted with 1 and resolved by SDS^PAGE and avidin blotting. A strongly labeled 55 kDa protein was identi¢ed only in the cALDH-I-
transfected cells. C: Sulfonate 1 labels recombinant cALDH-I in prokaryotic expression systems. A protein sample of E. coli BL-21 cells transformed
with a His-tagged version of cALDH-I was reacted with 1 and resolved by SDS^PAGE and avidin blotting. A strongly labeled 60 kDa protein was
identi¢ed, corresponding to the predicted molecular mass of cALDH-I with an appended N-terminal histidine tag. D: Reactivity of recombinantly ex-
pressed cALDH-I with members of the sulfonate library. Sulfonate probes (numbers shown above lanes) were reacted with cALDH-I-transfected COS-7
extracts and the reactions comparatively analyzed by SDS^PAGE and avidin blotting. A mock-transfected COS extract treated with sulfonate 1 was
also run as a control. Note that the relative reactivity of sulfonates with the COS-expressed cALDH-I enzyme (arrowhead) matched closely their relative
labeling e⁄ciencies with the 55 kDa protein of the testis proteome (Fig. 2). Top and bottom panels represent 1 and 5 min ¢lm exposures, respectively.
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(20 mM Tris^HCl, pH 8.0, 100 mM NaCl, 1 mM DTT)
for 60 min prior to the addition of cALDH-I did not a¡ect
the inhibitor’s potency, indicating that this sulfonate was
stable to the assay conditions employed (including the
presence of excess free thiols).
To probe the nature of 15’s interaction with cALDH-I,
competition studies were performed with both propional-
dehyde and NAD. Recombinant cALDH-I was treated
with 10 WM 15 for 10 min either in the presence or absence
of 25 WM propionaldehyde or 50 WM NAD and the
percentage of enzyme activity remaining was determined
(Table 1). Propionaldehyde had no detectable e¡ect on
15’s inactivation kinetics. In contrast, 50 WM NAD sig-
ni¢cantly reduced 15’s inhibition of cALDH-I, and higher
concentrations of NAD completely protected the enzyme
from inactivation (data not shown).
2.7. Features of pyridylsulfonates responsible for cALDH-I
inactivation
Analogs of 15 were synthesized in which the agent’s
octyl and pyridyl substituents were replaced with ethyl
(16) and methyl (17) groups, respectively. cALDH-I was
incubated for 60 min with 50 WM of either 15, 16, or 17,
and the percentage of cALDH-I activity remaining was
determined. While 15 completely inactivated cALDH-I
under these conditions, 16 and 17 produced weak and
no inhibition, respectively. A Kobs/[I] value of 0.25 M31
min31 was calculated for 16, representing a second order
inhibition rate constant 40 000 times lower than that de-
termined for 15. 15^17 were also tested for their ability to
block sulfonate 1’s reactivity with cALDH-I in the soluble
testis proteome. The testis proteome was preincubated for
30 min with each non-biotinylated sulfonate at concentra-
tions of 5 or 50 WM. The proteome samples were then
treated with 5 WM 1 and the reaction mixtures incubated
for 30 min prior to analysis by SDS^PAGE and avidin
blotting. Consistent with the inhibition kinetics described
above, only 15 blocked the labeling of cALDH-I by 1 in
the testis proteome (Fig. 6B). Collectively, these data high-
light that the interaction of sulfonate 1 with cALDH-I
depends on the chemical nature of both the linker and
binding groups of the inhibitor.
2.8. Multiplexing ABPs increases proteome coverage
Although individually, biotinylated sulfonates only pro-
¢led a modest fraction of the proteome, their application
together, or in combination with other ABPs (‘multiplex-
ing’) may signi¢cantly augment the number of proteins
visualized in a single assay. To test this notion, the rat
testis proteome was treated with either 2.5 WM sulfonate
1, 5 WM FP-biotin, or a mixture of 2.5 WM 1 and 5 WM
FP-biotin [14], and the resulting heat-sensitive labeling
pro¢les were visualized by SDS^PAGE and avidin blot-
ting. As can be seen in Fig. 7, applying a mixture of
sulfonate 1 and FP-biotin to the testis proteome e¡ectively
detected in a single sample the proteins labeled by both
probes individually. Notably, a preheated sample treated
with the same probe mixture displayed a very low level of
labeling that was comparable to the non-speci¢c reactivity
observed when each probe was tested alone. These data
suggest that by multiplexing ABPs, one can signi¢cantly
Fig. 6. Sulfonates are time-dependent inhibitors of cALDH-I. A: Time-
dependent inactivation of cALDH-I as a function of sulfonate 15 con-
centration. Recombinant, puri¢ed cALDH-I was incubated with di¡er-
ent concentrations of 15 and at the time points shown, aliquots of the
reaction were removed and assayed for enzyme activity using 1 mM
propionaldehyde and 0.5 mM NAD as substrate and cofactor, respec-
tively. Concentrations of 15 were: solid diamonds, 2.5 WM; hollow dia-
monds, 5 WM; solid circles, 7.5 WM; hollow circles, 10 WM; solid
squares, 15 WM. B: Competition reactions between sulfonate 1 and
structural analogs 15^17. Sulfonate 15 e¡ectively blocked the labeling of
cALDH-I by 1 in the testis proteome. Analogs of 15 in which this sul-
fonate’s pyridyl and octyl groups were replaced with methyl and ethyl
groups, respectively (16 and 17, respectively), did not block the labeling
of cALDH-I by 1.
Table 1
Competition studies for 15 with propionaldehyde and NAD in
cALDH
Substrate Sulfonate 15 (WM) Activity remaining (%)
^ ^ 100
^ 5 15
50 WM NAD 5 61
25 WM Propionaldehyde 5 14
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increase the coverage of speci¢c protein reactivities detect-
able in a single proteome assay.
3. Discussion
Genomics and proteomics aim to characterize on a
global level changes in the expression of genes and pro-
teins, respectively. Both methods generate data that are
anticipated to re£ect dynamics in molecular and cellular
function. Considering that proteins are the main compo-
nents of the cell responsible for executing its various ac-
tivities, proteomics data could be viewed as bringing one
conceptually closer to the goal of understanding complex
cellular function. However, proteomics initiatives face seri-
ous methodological challenges that have limited their im-
pact, especially when compared to the technically more
feasible ¢eld of genomics. To date, the ¢eld of proteomics
has relied primarily on 2DE and MS as its separation and
detection methods, respectively [11^13]. Although a signif-
icant fraction of the proteome can be analyzed with 2DE-
MS methods, numerous classes of proteins remain unde-
tected, including very large/small, highly basic/acidic,
membrane, and low abundance proteins [11^13]. More-
over, by measuring changes in protein abundance, stan-
dard proteomics experiments provide only an indirect as-
sessment of dynamics in protein activity.
We have initiated a research program aimed at generat-
ing chemical probes that pro¢le components of the pro-
teome in an activity-dependent manner. For example, a
biotinylated £uorophosphonate (FP-biotin) was recently
described that acts as an ABP for the serine hydrolase
superfamily of enzymes [14]. Similarly, other researchers
have generated biotinylated epoxides and electrophilic ke-
tones as pro¢ling agents for subclasses of cysteine pro-
teases [15^17]. Each of these ABPs measures changes in
enzyme activity directly in complex proteomes, thereby
o¡ering a global visualization of dynamics in protein func-
tion independent of changes in protein abundance. Addi-
tionally, an ABP’s biotin tag serves not only as a sensitive
detection device for classes of low abundance and bio-
chemically problematic proteins (e.g. membrane proteins;
our unpublished data), but also as a means for rapidly
isolating and identifying labeled proteins using avidin-
based solid supports.
In the design of ABPs that targeted serine and cysteine
hydrolases, researchers exploited a set of thoroughly char-
acterized active site-directed reactive groups and/or chem-
ical structures. However, for many enzyme and protein
families, well-de¢ned a⁄nity labeling reagents have not
yet been identi¢ed. In order to expedite the discovery of
new ABPs that show protein selectivities and reactivities
compatible with complex proteome analyses, we have syn-
thesized a library of biotinylated sulfonate esters and ap-
plied these agents to complex proteomes using an assay
that distinguished their speci¢c and non-speci¢c protein
reactivities. This assay involved comparing a sulfonate’s
reactivity with native and heat-denatured versions of the
proteome. Proteins that showed heat-sensitive sulfonate
reactivity were considered ‘speci¢c protein targets’, while
those that were labeled in both native and heat-denatured
proteomes were de¢ned as ‘non-speci¢c protein targets’.
We hypothesized that proteins reacting with members of
the sulfonate library in a heat-sensitive manner would
likely possess structured sites for small molecule interac-
tion, and that these sites would often determine the bio-
logical activity of the protein (e.g. ligand binding pockets
of receptors or active sites of enzymes). In such cases,
sulfonate labeling was hoped to a¡ect the function of
the protein target.
Members of the sulfonate library displayed strikingly
di¡erent speci¢c and non-speci¢c proteome reactivities.
At low micromolar concentrations, most sulfonates exhib-
ited heat-sensitive reactivity with a discrete number of
proteins, while at the same time showing very low or neg-
ligible reactivity with the heat-denatured proteome. Indi-
vidual sulfonates displayed unique patterns of speci¢c re-
activity, and even subtle variations in the sulfonate’s
binding group resulted in signi¢cant changes in proteome
labeling. For example, the pyridyl (1), benzene (2), and p-
tosyl (3) sulfonates, despite their structural similarity, all
displayed distinct speci¢c proteome reactivities, with 1 la-
beling 31 and 55 kDa proteins, 2 labeling 32, 42, and 55
kDa proteins, and 3 labeling exclusively a 55 kDa protein.
A few sulfonates, like the p-methoxybenzenesulfonate 4,
exhibited a high degree of non-speci¢c reactivity, labeling
numerous proteins in both heat-denatured and native pro-
teomes. All of these non-speci¢c targets represented pro-
teins of high abundance (as judged by Coomassie blue
staining), suggesting that a sulfonate’s heat-insensitive la-
beling was more re£ective of its intrinsic reactivity than a
Fig. 7. Multiplexing ABPs increases the number of protein activities de-
tected in a single proteome. Shown is a comparison of the heat-sensitive
labeling patterns of a testis proteome treated with pyridylsulfonate 1
(2.5 WM), FP-biotin (4 WM), or a mixture of pyridylsulfonate 1 (2.5
WM) and FP-biotin (4 WM). The mixture-treated proteome exhibited a
labeling pro¢le similar to that predicted from merging the pro¢les of
the proteome treated with each ABP alone.
CHBIOL 57 7-2-01
Research Paper Speci¢c reactivity of the proteome G.C. Adam et al. 89
selective association with particular constituents of the
proteome. In contrast, the sulfonate library’s heat-sensitive
labeling showed no such bias towards abundant proteins,
indicating that these reactivities resulted from speci¢c
small molecule^protein interactions. We speculate that
an expanded library of ABPs in which not only the bind-
ing group, but also the linker and reactive group are var-
ied will uncover additional probes that display distinct
patterns of speci¢c proteome reactivity.
Perhaps not surprisingly, the ratio of a sulfonate’s spe-
ci¢c versus non-speci¢c reactivity depended strongly on
the concentration of the agent applied to the proteome.
For example, sulfonate 1 showed negligible heat-insensi-
tive labeling at 1^5 WM concentrations, but as its concen-
tration approached 50 WM, the probe began to label nu-
merous proteins in both the native and heat-denatured
proteomes. Interestingly, no additional heat-sensitive reac-
tivities were detected when the concentration of 1 was
raised from 5 to 50 WM. Collectively, these data highlight
the importance of determining for a given electrophilic
probe the concentration range over which the agent’s ratio
of speci¢c versus non-speci¢c reactivity is maximized.
To examine the sulfonate library’s speci¢c proteome re-
activities in more detail, a heat-sensitive 55 kDa protein
target was isolated by avidin-based a⁄nity chromatogra-
phy and identi¢ed as cALDH-I. ALDHs constitute a
superfamily of enzymes that utilize the cofactor NAD
(NADP) to oxidize exogenous and endogenous aldehydes
to carboxylic acids through formation of a thioester inter-
mediate with an active site cysteine nucleophile [28^30].
The ALDH family is divided into three subclasses : the
homotetrameric cytosolic class I and the mitochondrial
class II isoforms and the homodimeric cytosolic class III
isoforms [25,27]. Genome sequencing projects have identi-
¢ed numerous ALDHs in Drosophila melanogaster (28
ALDHs), Caenorhabditis elegans (13 ALDHs), and Sac-
charomyces cerevisiae (13 ALDHs) [31]. In humans, at
least 16 ALDH genes have already been characterized
[32]. Mammalian ALDHs are noted for their roles in ret-
inoic acid biosynthesis [33], the detoxi¢cation of nitrogen-
mustard based chemotherapeutic agents [34^36], and the
catabolism of ethanol to acetic acid [37]. cALDH-I, a
quantitatively minor, though widely distributed cytosolic
protein, appears to function in the retinoid signaling path-
way by catalyzing the irreversible oxidation of retinal to
retinoic acid [38,39].
The heat-sensitive reactivity of cALDH-I with sulfonate
1 was con¢rmed by expressing this enzyme in both eukary-
otic and prokaryotic systems. Additionally, sulfonate 15 (a
non-biotinylated version of 1) was found to act as a time-
dependent irreversible inhibitor of cALDH-I, exhibiting a
kobs/[I] value of 9.7U103 M31 min31 (similar inhibitory
properties were observed for sulfonate 1 ; data not shown).
Excess NAD protected cALDH-I from inhibition by 15
(as well as from labeling by 1 in complex proteomes; data
not shown), consistent with the notion that this sulfonate
labeled cALDH-I at or near its active site. Analogs of 15
in which the agent’s pyridyl and octyl groups were re-
placed with methyl and ethyl groups, respectively, were
inactive as cALDH-I inhibitors, indicating that both the
binding group and linker components of 15 contributed
signi¢cant binding interactions. Nonetheless, saturation
kinetics could not be achieved with 15 even at concentra-
tions as high as 20 WM, indicating that its binding a⁄nity
for cALDH-I is relatively weak. These data, in conjunc-
tion with the recognition that sulfonate 1 reacted with
only two proteins in the testis proteome, suggest that an
ABP displaying a combination of tempered reactivity and
modest binding a⁄nity can engage in protein labeling
events of high selectivity.
The relatively potent and selective inhibition of
cALDH-I by 15 raises several intriguing issues. First,
what is the mechanism by which 15 reacts with cALDH-
I? Although it is attractive to speculate that the enzyme’s
cysteine nucleophile represents the site of sulfonate label-
ing, the cALDH-I^15 adduct has not yet been isolated and
characterized. If cALDH-I’s nucleophile does prove to be
the site of reactivity, then sulfonates appended with the
appropriate binding group(s) could act as active site-di-
rected pro¢ling agents for the ALDH family as a whole.
Indeed, considering that many ALDHs are 55 kDa in size,
at present we cannot exclude the possibility that our sul-
fonate library is reacting with more than one ALDH in the
proteome. Finally, sulfonates like 15 could serve as lead
compounds for the generation of highly selective and po-
tent inhibitors of ALDHs, an enzyme family of signi¢cant
therapeutic importance. On this note, disul¢ram, a rela-
tively non-selective ALDH inhibitor, has been used clini-
cally for many years in alcohol aversion therapy [40].
However, disul¢ram’s therapeutic utility is limited by its
high reactivity in vivo, resulting in the non-speci¢c carba-
moylation of several serum and cellular proteins [41,42]
and glutathione [43]. Thus, more selective and potent
ALDH inhibitors may ¢nd application in the treatment
of alcoholism, as well as various forms of cancer [34^36].
4. Signi¢cance
The chemical and biochemical approaches described
herein represent an alternative strategy for analyzing the
proteome that is both complementary and in some aspects
superior to the standard 2DE-MS methods currently in
practice. By treating complex proteomes with a library
of chemical probes bearing a moderately reactive sulfonate
ester, diverse patterns of speci¢c protein reactivity were
identi¢ed. Probes were characterized in terms of their
heat-sensitive protein labeling patterns, permitting the dis-
covery of reagents that pro¢led proteins based on proper-
ties other than abundance. Although such ABPs when
applied individually to the proteome detected only a lim-
ited set of proteins, their utility in combination should
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greatly enhance the characterization of a large number of
low abundance proteins. Finally, the discovery that sulfo-
nate probes not only labeled cALDH-I in complex pro-
teomes, but also inhibited this enzyme’s catalytic activity
suggests that, at least in this one example, a screen for
heat-sensitive labeling events accurately identi¢ed a small
molecule^protein reaction that impacted the protein’s bio-
logical function. If this correlation proves generalizable,
non-directed approaches for pro¢ling the speci¢c reactivity
of the proteome may generate chemical reagents applica-
ble for both proteomics investigations and cell-based func-
tional screens. In this latter case, one could envision
screening a library of ABPs for compounds that possess
a particular cellular bioactivity, and then comparing the
proteome labeling patterns of biologically active and in-
active library members to identify the a¡ected protein tar-
get(s).
5. Materials and methods
5.1. Synthesis alkyl and aryl sulfonate esters
All reactions were carried out under an atmosphere of argon
unless speci¢ed. Methylene chloride (CH2Cl2) was dried by pass-
ing through activated alumina columns. Commercial reagents of
high purity were purchased and used without further puri¢cation
unless otherwise noted. Nuclear magnetic resonance (NMR) spec-
tra were obtained on a Bruker AMX-400 instrument and cali-
brated to the residual solvent peak. The multiplicities are abbre-
viated as follows: s = singlet, d = doublet, t = triplet, q = quartet,
p = pentet, m = multiplet).
The synthesis of 10-((2-pyridylsulfonyl)oxo)-N-biotinamido-
pentyldecanamide (1) is provided as a representative synthesis
of the 11 biotinylated alkyl and aryl sulfonates (1^11).
5.1.1. ((2-Pyridylsulfonyl)oxo)-10-undecene (13)
A solution of g-undecylenyl alcohol (12) (0.50 g, 2.91 mmol,
1.0 equivalents (equiv.)) in pyridine (4 ml) was cooled to 0‡C and
treated with 2-pyridylsulfonyl chloride (1.04 g, 5.87 mmol, 2.0
equiv.), prepared according to the procedure of Corey and col-
leagues [44]. The reaction mixture was kept at 0‡C for 6 h, then
partitioned between ethyl acetate (50 ml) and water (25 ml). The
organic layer was washed with 10% aqueous HCl (2U50 ml) and
saturated aqueous NaCl (50 ml), dried (MgSO4), and concen-
trated under reduced pressure. Column chromatography (2%
EtOAc/Hex) a¡orded 13 as a colorless oil (98%): 1H NMR
(CDCl3, 400 MHz), N 8.61 (m, 1H, ArH), 7.89 (m, 2H, ArH),
7.47 (m, 1H, ArH), 5.67^5.60 (m, 1H, RCHNCH2), 4.84^4.74
(m, 2H, RCH = CH2), 4.21 (t, J = 6.4 Hz, 2H, CH2OSO2Pyr),
1.88 (m, 2H, CH2CHNCH2), 1.55 (p, 2H, J = 6.8 Hz, 2H,
CH2CH2OSO2Pyr), 1.20^1.08 (m, 12H); MALDI-FTMS
334.1433 (C16H25NO3S+Na requires 334.1447).
5.1.2. 10-((2-Pyridylsulfonyl)oxo)-decanoic acid (14)
Compound 13 (0.90 g, 2.88 mmol, 1 equiv.) in a biphasic so-
lution composed of CCl4^CH3CN^H2O (10 ml^10 ml^15 ml)
with a total volume of 35 ml was treated sequentially with sodium
periodate (2.53 g, 11.80 mmol, 4.1 equiv.) and ruthenium trichlo-
ride hydrate (0.005 g, 0.02 mmol, 0.03 equiv.). The reaction was
stirred at 25‡C overnight then partitioned between CH2Cl2 (100
ml) and 1 N aqueous HCl (2U100 ml). The organic layer was
washed with saturated aqueous NaCl (100 ml), dried (MgSO4)
and concentrated under reduced pressure. Column chromatogra-
phy (40% EtOAc/Hex) a¡orded 14 (80%): 1H NMR (CDCl3, 400
MHz), N 8.84 (d, J = 4.0 Hz, 1H, ArH), 8.11 (d, J = 5.9 Hz, 1H,
ArH), 8.05 (t, J = 6.0 Hz, 1H, ArH), 7.65 (t, J = 3.3 Hz, 1H,
ArH), 4.37 (t, J = 6.6 Hz, 2H, CH2OSO2Pyr), 2.34 (t, J = 7.4
Hz, 2H, CH2COOH), 1.70 (p, J = 8.0 Hz, 2H, CH2CH2COOH),
1.61 (p, J = 7.3 Hz, 2H, CH2CH2OSO2Pyr), 1.25 (m, 10H):




A solution of 14 (0.030 g, 0.09 mmol, 10 equiv.) in CH2Cl2 (1.5
ml) at 378‡C was treated dropwise with (diethylamino)sulfur
tri£uoride (0.027 ml, 0.21 mmol, 22 equiv.), brought to 25‡C,
and stirred for 10 min. The reaction was then treated with one-
half reaction volume of dimethylformamide containing N-hy-
droxysuccinimide (0.05 g, 0.04 mmol, 40 equiv.) and stirred for
an additional 15 min at 25‡C. The reaction mixture was partitioned
between ethyl acetate (50 ml) and water (50 ml). The organic layer
was washed with saturated aqueous NaCl (200 ml), dried
(Na2SO4), and concentrated under reduced pressure to a¡ord
10-((2-pyridylsulfonyl)oxo)-N-(hydroxysuccinyl)decanamide (as
judged by crude 1H NMR; data not shown). Without further
puri¢cation, the intermediate was treated with 5-(biotinamido)-
pentylamine (Pierce, 0.003 g, 0.009 mmol, 1.0 equiv.) in MeOH
(0.04 ml) and stirred for 30 min. The solvent was evaporated
under a stream of nitrogen, and the remaining residue was
washed with ethyl acetate (2U2.5 ml), solubilized in a minimal
volume of chloroform, transferred to a clean glass vial, and the
solvent evaporated. This process was repeated to rid the desired
biotinylated product of excess reagents and byproducts, a¡ording
4 as a white ¢lm (0.004 g, 46%): 1H NMR (CDCl3, 400 MHz),
N 8.79 (d, J = 7.0 Hz, 1H, ArH), 8.06 (m, 2H, ArH), 7.61 (t, J = 7.3
Hz, 1H, ArH), 6.05 (b s, 1H, NH), 5.91 (b s, 1H, NH), 5.60 (b s,
1H, NH), 4.77 (b s, 1H, NH), 4.54 (m, 1H), 4.39 (m, 1H+2H,
CH2OSO2R), 3.22 (m, 4H, CH2NHCOR), 3.11 (m, 1H), 2.92 (dd,
J = 4.0 and 12.9 Hz, 1H), 2.76 (d, J = 13.3 Hz, 1H), 2.18 (m, 4H,
CH2CONHR), 1.67^1.28 (m, 26H); MALDI-FTMS (DHB) m/z
640.3209 (C30H49N5O6S2+H requires 640.3202).
5.1.4. 10-((Benzenesulfonyl)oxo)-N-biotinamidopentyldecanamide
(2)
1H NMR (CDCl3, 400 MHz), N 7.93 (d, J = 7.0 Hz, 2H, ArH),
7.67 (t, J = 7.4 Hz, 1H, ArH), 7.59 (t, J = 7.3 Hz, 2H, ArH), 6.06
(b s, 1H, NH), 5.87 (b s, 1H, NH), 5.63 (b s, 1H, NH), 4.79 (b s,
1H, NH), 4.53 (m, 1H), 4.37 (m, 1H), 4.07 (t, J = 6.4 Hz, 2H,
CH2OSO2R), 3.26 (m, 4H, CH2NHCOR), 3.09 (m, 1H), 2.93 (dd,
J = 5.0 and 7.9 Hz, 1H), 2.76 (d, J = 13.0 Hz, 1H), 2.19 (m, 4H,
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CH2CONHR), 1.62^1.26 (m, 26H); MALDI-FTMS (DHB) m/z
639.3244 (C31H50N4O6S2+H requires 639.3245).
5.1.5. 10-((p-Toluenesulfonyl)oxo)-N-biotinamidopentyl-
decanamide (3)
1H NMR (CDCl3, 400 MHz), N 7.78 (d, J = 8.5 Hz, 2H, ArH),
7.37 (d, J = 7.9 Hz, 2H, ArH), 5.91 (b s, 1H, NH), 5.84 (b s, 1H,
NH), 5.49 (b s, 1H, NH), 4.76 (b s, 1H, NH), 4.53 (m, 1H), 4.35
(m, 1H), 4.02 (t, J = 6.4 Hz, 2H, CH2OSO2R), 3.25 (m, 4H,
CH2NHCOR), 3.18 (m, 1H), 2.93 (dd, J = 5.0 and 7.9 Hz, 1H),
2.76 (d, J = 12.9 Hz, 1H), 2.46 (s, 3H, CH3Ar), 2.19 (m, 4H,
CH2CONHR), 1.70^1.50 (m, 26H); MALDI-FTMS (DHB) m/z
653.3381 (C32H52N4O6S2+H requires 653.3401).
5.1.6. 10-((4-Methoxybenzenesulfonyl)oxo)-N-biotinamidopentyl-
decanamide (4)
1H NMR (CDCl3, 400 MHz), N 7.86 (d, J = 8.8 Hz, 2H, ArH),
7.03 (d, J = 8.8 Hz, 2H, ArH), 5.96 (b s, 1H, NH), 5.85 (b s, 1H,
NH), 5.57 (b s, 1H, NH), 4.84 (b s, 1H, NH), 4.53 (m, 1H), 4.37
(m, 1H), 4.01 (t, J = 6.5 Hz, 2H, CH2OSO2R), 3.90 (s, 3H,
CH3OAr), 3.25 (m, 4H, CH2NHCOR), 3.17 (m, 1H), 2.95 (dd,
J = 4.7 and 7.7 Hz, 1H), 2.73 (d, J = 12.9 Hz, 1H), 2.25 (m, 4H,
CH2CONHR), 1.63^1.26 (m, 26H); MALDI-FTMS (DHB) m/z
669.3381 (C32H52N4O7S2+H requires 669.335).
5.1.7. 10-((Methylsulfonyl)oxo)-N-biotinamidopentyldecanamide
(5)
1H NMR (CDCl3, 400 MHz), N 6.00 (b s, 1H, NH), 5.85 (b s,
1H, NH), 5.60 (b s, 1H, NH), 4.81 (b s, 1H, NH), 4.53 (m, 1H),
4.37 (m, 1H), 4.35 (t, J = 6.2 Hz, 2H, CH2OSO2R), 3.26 (m, 4H,
CH2NHCOR), 3.18 (m, 1H), 2.93 (dd, J = 5.0 and 7.9 Hz, 1H),
2.76 (d, J = 12.9 Hz, 1H), 2.21 (m, 4H, CH2CONHR), 2.05 (s,
3H, H3CSO3R), 1.75^1.27 (m, 26H); MALDI-FTMS m/z
577.3105 (C26H48N4O6S2+H requires 577.3088).
5.1.8. 10-((Butylsulfonyl)oxo)-N-biotinamidopentyldecanamide
(6)
1H NMR (CDCl3, 400 MHz), N 5.93 (b s, 1H, NH), 5.84 (b s,
1H, NH), 5.53 (b s, 1H, NH), 4.82 (b s, 1H, NH), 4.54 (m, 1H),
4.37 (m, 1H), 4.21 (t, J = 6.2 Hz, 2H, CH2OSO2R), 3.26 (m, 4H,
CH2NHCOR), 3.19 (m, 1H), 3.09 (t, J = 4.1 Hz, 2H, CH2SO3R),
2.93 (dd, J = 4.6 and 7.4 Hz, 1H), 2.76 (d, J = 9.1 Hz, 1H), 2.21
(m, 4H, CH2CONHR), 2.16^1.31 (m, 30H), 0.97 (t, J = 7.3 Hz,




1H NMR (CDCl3, 400 MHz), N 6.05 (b s, 1H, NH), 5.87 (b s,
1H, NH), 5.81 (b s, 1H, NH), 5.00 (b s, 1H, NH), 4.53 (m, 1H),
4.35 (m, 1H), 4.21 (t, J = 6.2 Hz, 2H, CH2OSO2R), 3.25 (m, 4H,
CH2NHCOR), 3.17 (m, 1H), 3.09 (t, J = 8.5 Hz, 2H, CH2SO3R),
2.93 (dd, J = 4.7 and 7.9 Hz, 1H), 2.76 (d, J = 12.9 Hz, 1H), 2.19
(m, 4H, CH2CONHR), 1.86 (p, J = 7.9 Hz, 2H, CH2CH2SO3R),
1.76^1.31 (m, 36H), 0.89 (t, J = 6.4 Hz, 3H); MALDI-FTMS
(DHB) m/z 675.4173 (C33H62N4O6S2+H requires 675.4184).
5.1.10. 10-((4-Nitrobenzenesulfonyl)oxo)-N-biotinamidopentyl-
decanamide (8)
1H NMR (CDCl3, 400 MHz), N 8.44 (d, J = 9.1 Hz, 2H, ArH),
8.14 (d, J = 9.1 Hz, 2H, ArH), 5.90 (b s, 1H, NH), 5.82 (b s, 1H,
NH), 5.50 (b s, 1H, NH), 4.86 (b s, 1H, NH), 4.54 (m, 1H), 4.37
(m, 1H), 4.14 (t, J = 6.5 Hz, 2H, CH2OSO2R), 3.25 (m, 4H,
CH2NHCOR), 3.18 (m, 1H), 2.96 (dd, J = 5.0 and 7.9 Hz, 1H),
2.76 (d, J = 15.0 Hz, 1H), 2.21 (m, 4H, CH2CONHR),




1H NMR (CDCl3, 400 MHz), N 9.17 (m, 1H, ArH), 8.53
(d, J = 5.8 Hz, 1H, ArH), 8.50 (d, J = 6.4 Hz, 1H, ArH), 8.16
(d, J = 6.7 Hz, 1H, ArH), 7.70 (t, J = 7.6 Hz, 1H, ArH), 7.61
(q, J = 3.9 Hz, 1H, ArH), 6.06 (b s, 1H, NH), 5.93 (b s, 1H,
NH), 5.73 (b s, 1H, NH), 5.08 (b s, 1H, NH), 4.54 (m, 1H),
4.35 (m, 1H), 4.30 (t, J = 6.5 Hz, 2H, CH2OSO2R), 3.27 (m,
4H, CH2NHCOR), 3.18 (m, 1H), 2.96 (dd, J = 5.0 and 7.9 Hz,
1H), 2.77 (d, J = 15 Hz, 1H), 2.21 (m, 4H, CH2CONHR), 1.68^




1H NMR (CDCl3, 400 MHz), N 8.49 (s, 1H, ArH), 7.98 (t,
J = 8.2 Hz, 2H, ArH), 7.93 (d, J = 7.9 Hz, 1H, ArH), 7.87 (d,
J = 8.8 Hz, 1H, ArH), 7.65 (p, J = 7.0 Hz, 2H, ArH), 6.05 (b s,
1H, NH), 5.91 (b s, 1H, NH), 5.60 (b s, 1H, NH), 4.77 (b s, 1H,
NH), 4.53 (m, 1H), 4.37 (m, 1H), 4.06 (t, J = 6.4 Hz, 2H,
CH2OSO2R), 3.25 (m, 4H, CH2CONHR), 3.17 (m, 1H), 2.95
(dd, J = 5.0 and 7.6 Hz, 1H), 2.77 (d, J = 14.0 Hz), 2.17 (m, 4H,
CH2CONHR), 1.71^1.20 (m, 26H); MALDI-FTMS (DHB) m/z
689.3379 (C35H52N4O6S2+H requires 689.3401).
5.1.13. 10-((2-Thiophenesulfonyl)oxo)-N-biotinamidopentyl)-
decanamide (11)
1H NMR (CDCl3, 400 MHz), N 7.74 (t, J = 5.0 Hz, 2H, ArH),
7.16 (t, J = 3.8 Hz, 1H, ArH), 5.90 (b s, 1H, NH), 5.84 (b s, 1H,
NH), 5.47 (b s, 1H, NH), 4.75 (b s, 1H, NH), 4.53 (m, 1H), 4.35
(m, 1H), 4.12 (t, J = 6.4 Hz, 2H, CH2OSO2R), 3.26 (m, 4H,
CH2NHCOR), 3.19 (m, 1H), 2.95 (dd, J = 5.3 and 7.6 Hz, 1H),
2.76 (d, J = 12.9 Hz, 1H), 2.17 (m, 4H, CH2CONHR),
1.67^1.26 (m, 26H); MALDI-FTMS (DHB) m/z 645.2817
(C29H48N4O6S3+H requires 645.2809).
5.1.14. 1-(2-Pyridylsulfonyl)oxo-octane (15)
To 3.0 ml of anhydrous triethylamine (23.04 mmol, 30 equiv.)
at 0‡C was added 1-octanol (0.10 g, 0.77 mmol, 1 equiv.) fol-
lowed by the addition of 2-pyridylsulfonyl chloride in one por-
tion. The mixture was kept at 0‡C for 3 h followed by the addi-
tion of water (5 ml). The resulting mixture was extracted with
diethyl ether (3U50 ml), then the organic extracts were combined
and washed with aqueous NaHCO3 solution (50 ml), dried
(MgSO4), and concentrated under reduced pressure. Column
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chromatography (2% EtOAc/Hex) a¡orded 15 (99%): 1H NMR
(CDCl3, 400 MHz), N 8.68 (d, J = 7.0 Hz, 1H, ArH), 7.94 (p,
J = 8.8 Hz, 2H, ArH), 7.54 (t, J = 6.4 Hz, 1H, ArH), 4.26 (t,
J = 6.7 Hz, 2H, CH2OSO2R), 1.61 (p, J = 7.9 Hz, 2H), 1.13 (m,
10H), 0.76 (t, J = 7.0 Hz, 3H); MALDI-FTMS 294.1130
(C13H21NO3S+Na requires 294.1134).
5.1.15. 1-(2-Pyridylsulfonyl)oxo-ethane (16)
To a solution of triethylamine (0.86 g, 8.51 mmol, 2.2 equiv.) in
dichloromethane (3 ml) at 0‡C was added ethanol (0.18 g, 3.87
mmol, 1 equiv.) followed by the addition of 2-pyridylsulfonyl
chloride (0.83 g, 4.65 mmol, 1.2 equiv.). After stirring for 4 h
at 0‡C, the solution was concentrated under reduced pressure.
The concentrate was dissolved in aqueous NaHCO3 solution
(50 ml) and extracted with diethyl ether (3U50 ml). The ether
extracts were combined and washed with aqueous NaCl (50 ml),
dried (MgSO4), and concentrated under reduced pressure. Col-
umn chromatography (5% EtOAc/Hex) a¡orded 16 (95%): 1H
NMR (CDCl3, 400 MHz), N 8.70 (d, J = 4.7 Hz, 1H, ArH),
7.95 (p, J = 6.4 Hz, 2H, ArH), 7.56 (t, J = 5.3 Hz, 1H, ArH),
4.37 (q, J = 7.0 Hz, 2H, CH2OSO2R), 1.29 (t, J = 7.0 Hz, 3H);
MALDI-FTMS 188.0000 (C6H9NOS+H requires 188.0376).
5.1.16. 1-(Methanesulfonyl)oxo-octane (17)
To a solution of triethylamine (0.12 g, 1.15 mmol, 1.5 equiv.) in
dichloromethane (3 ml) was added octanol (0.10 g, 0.77 mmol,
1.0 equiv.) at 0‡C followed by the addition of methanesulfonyl
chloride (0.10 g, 0.85 mmol, 1.1 equiv.), over a period of 5 min.
After 30 min at 0‡C, the reaction mixture was diluted in dichloro-
methane (50 ml) and extracted with ice cold water (50 ml), ice
cold 10% aqueous HCl (50 ml), saturated aqueous NaHCO3 (50
ml), and with saturated aqueous NaCl (50 ml). The organic layer
was dried (MgSO4) and concentrated under reduced pressure to
a¡ord 17 (97%): 1H NMR (CDCl3, 400 MHz), N 4.21 (t, J = 6.5
Hz, 2H, CH2OSO2Me), 2.99 (s, 3H, CH3SO3), 1.77 (p, J = 6.7
Hz, 2H), 1.35 (m, 10 H), 0.87 (t, J = 6.1 Hz, 3H).
5.2. Proteome sample preparation, labeling, and detection
Rat tissues were Dounce-homogenized in Tris bu¡er (50 mM
Tris^HCl bu¡er, pH 8.0, 0.32 M sucrose). Tissue extracts were
centrifuged sequentially at 1100Ug (10 min), 22 000Ug (30 min),
and 105 000Ug (60 min). The ¢nal supernatant (soluble fraction)
was adjusted to 0.5 mg protein/ml with Tris bu¡er (without su-
crose) and kept at 0‡C until utilized. Unless otherwise indicated,
reactions between protein samples and biotinylated reagents were
conducted as follows: all biotinylated reagents were stored as
stock solutions in DMSO at 320‡C and then added directly to
reactions with protein extracts, keeping the DMSO concentration
constant at 1% of the total reaction volume. The reaction mixture
was incubated at 25‡C for 30 min (¢nal concentration of the
probe was 5 WM), then quenched by the addition of 1 volume
equiv. of standard 2U SDS^PAGE loading bu¡er (reducing).
Quenched reactions were run on SDS^PAGE (7.5 Wg protein/
gel lane) and transferred by electroblotting onto nitrocellulose
membranes, which were blocked in Tris-bu¡ered saline (TBS)
with 1% Tween (TBS-Tween) and 3% (w/v) non-fat dry milk
for either 1 h at 25‡C or overnight at 4‡C. Blots were then treated
with an avidin^horseradish peroxidase conjugate (Bio-Rad,
1:1500 dilution) in TBS-Tween for 2 h at 25‡C. The blot was
washed with TBS-Tween three times (5 min/wash), treated with
SuperSignal chemiluminescence reagents (Bio-Rad), and exposed
to ¢lm for 0.1^20 min before development. For the pH-depen-
dence studies, the following reaction bu¡ers were used: pH 6^8:
50 mM Tris^HCl; pH 8^10: 50 mM Tris^HCl, 50 mM CAPS.
5.3. Enrichment and molecular characterization of a 55 kDa
sulfonate-reactive protein
Rat liver soluble fractions were run over a Q-Sepharose col-
umn by using an AKTA FPLC (Amersham Pharmacia Biotech)
and eluted with a linear gradient of 0^500 mM NaCl. Aliquots of
the elution fractions (10U2.5 ml fractions) as well as the £ow-
through (3U2.5 ml fractions) were labeled with 1 as described
above to identify the fractions containing the labeled proteins.
The £ow-through fractions, which contained the 55 kDa protein,
were concentrated to 1 mg protein/ml followed by labeling 2.5 ml
of the sample with 1 utilizing the standard conditions. After in-
cubating the reaction for 30 min, it was applied to a PD-10 size
exclusion column and eluted with 3.5 ml of pH 8, 50 mM Tris^
HCl bu¡er. SDS (0.5% w/v) was added and the labeled samples
heated to 90‡C for 10 min in order to denature the proteins
allowing for a more accessible biotin moiety. The sample was
then diluted 2.5-fold (0.2% SDS) and incubated with 50^100 Wl
of avidin beads on a rotator for 1 h at 25‡C. The eluant was then
removed followed by washing with 5 ml of 0.2% SDS and three
washes with pH 8, 50 mM Tris^HCl bu¡er. Standard 2U SDS^
PAGE loading bu¡er was added followed by heating the sample
to 90‡C in order to elute the proteins labeled with 1 from the
avidin beads. The eluant was run on an 8% Novex Tris^glycine
gel and stained with Coomassie blue stain followed by destaining
in a 30% methanol^water solution. The desired 55 kDa 1-reactive
protein was excised from the gel and digested with trypsin. The
resulting peptides were analyzed by MALDI-TOF MS. The
MALDI peptide data were utilized in both the MS-Fit search
of the Protein Prospector databases (falcon.ludwig.ucl.ac.uk/
mskome3.2.htm) and the ProFound search of the Proteometrics
databases (www.proteometrics.com/prowl-cgi/ProFound.exe),
which identi¢ed the protein as cALDH-I.
5.4. Recombinant expression and puri¢cation of cALDH-I
Primers were designed based on cALDH-I’s cDNA sequence
and used to amplify the enzyme’s cDNA from a liver cDNA li-
brary (Clontech). The cALDH-I cDNA was subcloned into the
prokaryotic expression vector, TrcHisA, sequenced, and trans-
formed into E. coli BL-21 cells. Expression was induced with
1 mM isopropyl L-D-thiogalactoside when cultures grew to an
OD600 of 0.6. After 4 h, the cells were pelleted and the supernatant
removed. The cell pellet was resuspended in Tris bu¡er (20 mM
Tris^HCl bu¡er, pH 8.0, 100 mM NaCl), lysed by treatment with
lysozyme (1 mg/ml) for 30 min and then sonication. The soluble
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fraction was isolated by centrifugation 39 800Ug (25 min). The
His-tagged cALDH-I was puri¢ed from the soluble fraction by
rotating with Talon cobalt beads for 30 min at 4‡C followed by
centrifugation and removal of the lysate. After washing, the beads
were eluted with 80 mM imidazole bu¡er and the eluted protein
concentrated to 10 mg protein/ml. The concentrated protein solu-
tion was subjected to gel ¢ltration chromatography (Superose 6
column, AKTA FPLC, Amersham Pharmacia Biotech). Gel ¢ltra-
tion samples containing puri¢ed cALDH-I were combined, con-
centrated, and stored at 378‡C in Tris bu¡er containing 1 mM
DTT (¢nal cALDH-I protein concentration, 1.5 mg/ml).
5.5. Expression of cALDH-I in eukaryotic cells
The cALDH-I cDNA was subcloned into the eukaryotic ex-
pression vector pcDNA3 and transiently transfected into COS-7
cells and MCF-7 cells by using methods described previously [14].
Transfected cells were harvested by scraping, resuspended in Tris
bu¡er and their protein concentrations determined (Dc protein
assay kit, Bio-Rad). Whole cell suspensions were labeled with
the sulfonate 1 as described above.
5.6. Characterization of sulfonate reactivity of cALDH-I
cALDH-I-transfected COS-7 cells were harvested by scraping,
resuspended in Tris bu¡er, Dounce-homogenized, and sonicated.
The soluble fraction was separated by centrifugation and the
protein concentration determined (Dc protein assay kit, Bio-
Rad). The soluble lysate (0.5 Wg/Wl) was incubated with each bio-
tinylated probe (2.5 WM, 1% DMSO) for 2 min at 25‡C in Tris
bu¡er (50 mM Tris^HCl, pH 8). A mock-transfected COS-7 sam-
ple was labeled with sulfonate 1 as a control. The reactions were
quenched and analyzed by SDS^PAGE and avidin blotting as
described above.
5.7. cALDH-I enzyme assay and inhibition studies
cALDH-I activity was determined at 25‡C in Tris bu¡er (20
mM Tris^HCl, pH 8, 100 mM NaCl). Puri¢ed cALDH-I (0.2
WM) was preincubated with 15 (2.5^15 WM) in DMSO (30 Wl,
3% total incubation volume) in a volume of 950 Wl for 5^45
min. After preincubation of the enzyme with inhibitor, remaining
catalytic activity was measured by adding NAD (500 WM ¢nal
concentration) and propionaldehyde (1 mM ¢nal concentration)
in 50 Wl of bu¡er. Production of NADH from the oxidation of
propionaldehyde was monitored by measuring the change in ab-
sorbance at 340 nm for 2 min. In substrate competition assays,
puri¢ed cALDH-I (0.2 WM) was preincubated with either NAD
(50 WM) or propionaldehyde (25 WM) and 10 WM of 15 for 10 min
at 25‡C in a volume of 950 Wl. Remaining catalytic activity was
monitored as described above.
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